| 000 | 01323 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512004408.0 | ||
| 264 | 0 | _c19890809 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0014-2980 | ||
| 024 | 7 |
_a10.1002/eji.1830190528 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRincón, M | |
| 245 | 0 | 0 |
_aInduction of T cell function via the gp33/27 activation inducer molecule (AIM) requires co-expression of the CD3/TcR complex. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _cMay 1989 |
||
| 300 |
_a959-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntigens, CD |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xphysiology |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 |
_aCalcimycin _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLectins, C-Type |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xphysiology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xphysiology |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aCebrián, M | |
| 700 | 1 | _aSánchez-Madrid, F | |
| 700 | 1 | _aLópez-Botet, M | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 19 _gno. 5 _gp. 959-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.1830190528 _zAvailable from publisher's website |
| 999 |
_c2531446 _d2531446 |
||